Conference Coverage
Conference Coverage
Should clinic BP be routinely measured lying down?
The data revealed that 16% of those without seated hypertension had supine hypertension, while 74% of those with seated hypertension had supine...
Conference Coverage
MS drugs during pregnancy show no safety signals
Data on outcomes from cladribine, ocrelizumab, ofatumumab, and ozanimod during pregnancy showed no miscarriages or malformations above the general...
Conference Coverage
Probiotics improve nonmotor symptoms of Parkinson’s
Participants taking the probiotic also saw a reduced delay in “time to on” of treatment with levodopa, thus reducing the delay until effectiveness...
Conference Coverage
Oral tau inhibitor continues to show promise in Alzheimer’s
“This is the first tau aggregation inhibitor to reach the phase 3 stage of development and to produce results like this.”
Conference Coverage
Cognitive benefit of highly touted MIND diet questioned
“Although we did not see a specific effect of the MIND diet, people in both groups improved their cognitive function.”
Conference Coverage
Infection-related chronic illness: A new paradigm for research and treatment
Researchers are looking to build a common research agenda for infection-related chronic illnesses to “understand the epidemiology and pathogenesis...
Conference Coverage
Research points toward combination therapy for Lyme and improved diagnostics
Lyme disease researchers are investigating combination therapy to address “persister” bacteria and diagnostic tests that test directly for the...
Conference Coverage
Chronic constipation linked to cognitive decline
“These results stress the importance of clinicians discussing gut health, especially constipation, with their older patients.”
Conference Coverage
Retinal thickness a new predictor of MS disability?
The imaging technique cannot be used for all patients and is currently not widely available.
Conference Coverage
Promising phase 3 results for Alzheimer’s drug donanemab
The TRAILBLAZER-ALZ 2 study showed significant slowing of disease progression.
Conference Coverage
U.S. states, counties with highest Alzheimer’s prevalence rates identified
“These new findings could help physicians treating or caring for minority populations “understand the landscape of what the disease looks like.”...